期刊文献+

应用免疫学快捷微波法检测100例乳腺癌耐药基因的分析

下载PDF
导出
摘要 目的:应用即用型快捷免疫组化MaxvisionTM微波修复抗原法检测肿瘤耐药基因。方法:随机选取100例乳腺癌组织标本,采用微波加热修复抗原法进行肿瘤基因检测。结果:100例乳腺癌中PgP、GST-л和ToPo的阳性表达率分别29/100、58/100和68/100,结果检测表明29%患者PgP阳性对阿霉素、长春新碱、VP16及紫杉醇等有一定耐药。58%患者GST-л阳性,提示对阿霉素、顺铂、氮介耐药。68%的患者ToPo阳性提示可用阿霉素类药。结论:检测肿瘤细胞的耐药基因,可指导乳腺癌的临床化疗前筛选出不具有耐药的联合用药方案。
出处 《华夏医学》 CAS 2008年第1期100-101,共2页 Acta Medicinae Sinica
  • 相关文献

参考文献2

二级参考文献7

  • 1Ferrero-Pous M,Hacene K,Bouchet C.Relationship between c-erbB-2and other tumor characteristics in breast cancer prognosis[J].Clin Cancer Res,2000,6(12):4745-4754.
  • 2Yu K,Lee CH,Tan PH.A moleeular signature of the Nottingham prognostic index in breast cancer[J].Cancer Res,2004,64 (9):2962-2980.
  • 3Ariazi EA,Clark GM,Mertz JE.Estrogen-related receptor alpha and estrogen-related receptor gamma associate with unfavorable and favorable biomarkers,respectively,in human breast cancer[J].Cancer Res,2002,62(22):6510-6518.
  • 4Joensuu H,Isola J,Lundin M.Amplifcation of erbB2 and erbB2expression are superior to estrogen receptor status as risk factors for distant recurrence in pT1NOMO breast cancer:a nationwide population-based study[J].Clin Cancer Res,2003,9(3):923-930.
  • 5Yoshida N,Omoto Y,Inoue A.Prediction of prognosis of estrogen receptor-positive breast cancer with combination of selected estrogenregulated genes[J].Cancer Sci,2004,95(6):496-502.
  • 6Kun Y,How LC,Hoon TP.Classifying the estrogen receptor status of breast cancers by expression profiles reveals a poor prognosis subpopulation exhibiting high expression of the ERBB2 receptor[J].Hum Mol Genet,2003,12(24):3245-3258.
  • 7Sotiriou C,Neo SY,McShane LM.Breast cancer classification and prognosis based on gene expression profiles from a population-based study[J].Proc Natl Acad Sci USA,2003,100(18):10393-10398.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部